CL
ClearPoint Neuro, Inc.
CLPT · NASDAQ
$13.72 +0.51% (+$0.07)
1M -11.02%
Market Cap $404.3M
P/E Ratio -
Div. Yield -
ROE 188.09%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 37.51x
P/S 9.56x
PEG N/A
Growth
78 /100
Growing Book val. growth 8.76%
Rev. growth 21.62%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 74.01%
Op. margin 73.42%
Gross margin 62.61%
Quality
6 /100
Poor Asset turnover 0.49x
ROA 39.85%
ROIC 40.49%
Debt
23 /100
High Current ratio 4.73x
Int. coverage -7.63x
Debt/Equity 5.93x
Stability
64 /100
Moderate Profitable years 0
EPS volatility 30.48%
Beta 1.27x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CLPT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Michael Burnett
Employees
172
Headquarters
Solana Beach
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report